Evaluating movement disorders in pediatric patients receiving risperidone: a comparison of spontaneous reports and research criteria for TD

por Pandina, Gahan J, Bossie, Cynthia A, Zhu, Young, Gharabawi, Georges M
Publicado 2007

Reduction in psychotic symptoms as a predictor of patient satisfaction with antipsychotic medication in schizophrenia: Data from a randomized double-blind trial

por Gharabawi, Georges M, Greenspan, Andrew, Rupnow, Marcia FT, Kosik-Gonzalez, Colette, Bossie, Cynthia A, Zhu, Young, Kalali, Amir H, Awad, A George
Publicado 2006

Maintenance therapy with once-monthly administration of long-acting injectable risperidone in patients with schizophrenia or schizoaffective disorder: a pilot study of an extended...

por Gharabawi, Georges M, Gearhart, Natalie C, Lasser, Robert A, Mahmoud, Ramy A, Zhu, Young, Mannaert, Erik, Naessens, Ineke, Bossie, Cynthia A, Kujawa, Mary, Simpson, George M
Publicado 2007

What Is Causing the Reduced Drug-Placebo Difference in Recent Schizophrenia Clinical Trials and What Can be Done About It?

por Kemp, Aaron S., Schooler, Nina R., Kalali, Amir H., Alphs, Larry, Anand, Ravi, Awad, George, Davidson, Michael, Dubé, Sanjay, Ereshefsky, Larry, Gharabawi, Georges, Leon, Andrew C., Lepine, Jean-Pierre, Potkin, Steven G., Vermeulen, An
Publicado 2010